Literature DB >> 18973805

Relationships among molecular genetic and respiratory properties of Parkinson's disease cybrid cells show similarities to Parkinson's brain tissues.

M Kathleen Borland1, K P Mohanakumar, Jeremy D Rubinstein, Paula M Keeney, Jing Xie, Roderick Capaldi, Lisa D Dunham, Patricia A Trimmer, James P Bennett.   

Abstract

We have studied sporadic Parkinson's disease (sPD) from expression of patient mitochondrial DNA (mtDNA) in neural cells devoid of their own mtDNA, the "cybrid" model. In spite of reproducing several properties of sPD brain, it remains unclear whether sPD cybrid cells reflect more complex sPD brain bioenergetic pathophysiology. We characterized and correlated respiration of intact sPD cybrid cells with electron transport chain (ETC) protein assembly, complex I ETC gene expression and ETC protein levels in sPD brain. We also assayed expression for multiple ETC genes coded by mtDNA and nuclear DNA (nDNA) in sPD cybrid cells and brain. sPD cybrid cells have reduced levels of mtDNA genes, variable compensatory normalization of mitochondrial gene expression and show robust correlations with mitochondrial ETC gene expression in sPD brains. Relationships among ETC protein levels predict impaired complex I-mediated respiration in sPD brain. That sPD cybrid cells and sPD brain samples show very correlated regulation of nDNA and mtDNA ETC transcriptomes suggests similar bioenergetic physiologies. We propose that further insights into sPD pathogenesis will follow elucidation of mechanisms leading to reduced mtDNA gene levels in sPD cybrids. This will require characterization of the abnormalities and dynamics of mtDNA changes propagated through sPD cybrids over time.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18973805      PMCID: PMC2655102          DOI: 10.1016/j.bbadis.2008.09.014

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  26 in total

1.  Neuropathology of dementia in Parkinson's disease: a prospective, community-based study.

Authors:  Dag Aarsland; Robert Perry; Andrew Brown; Jan P Larsen; Clive Ballard
Journal:  Ann Neurol       Date:  2005-11       Impact factor: 10.422

2.  Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family.

Authors:  R H Swerdlow; J K Parks; J N Davis; D S Cassarino; P A Trimmer; L J Currie; J Dougherty; W S Bridges; J P Bennett; G F Wooten; W D Parker
Journal:  Ann Neurol       Date:  1998-12       Impact factor: 10.422

3.  Where does parkinson disease pathology begin in the brain?

Authors:  Kelly Del Tredici; Udo Rüb; Rob A I De Vos; Jürgen R E Bohl; Heiko Braak
Journal:  J Neuropathol Exp Neurol       Date:  2002-05       Impact factor: 3.685

4.  Limbic neuropathology in idiopathic Parkinson's disease with concomitant dementia.

Authors:  Ewa Bertrand; Waldemar Lechowicz; Grazyna M Szpak; Eliza Lewandowska; Jerzy Dymecki; Teresa Wierzba-Bobrowicz
Journal:  Folia Neuropathol       Date:  2004       Impact factor: 2.038

5.  Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease.

Authors:  M Gu; J M Cooper; J W Taanman; A H Schapira
Journal:  Ann Neurol       Date:  1998-08       Impact factor: 10.422

Review 6.  Mitochondria in the aetiology and pathogenesis of Parkinson's disease.

Authors:  Anthony H V Schapira
Journal:  Lancet Neurol       Date:  2008-01       Impact factor: 44.182

7.  Mitochondrial function in Parkinson's disease cybrids containing an nt2 neuron-like nuclear background.

Authors:  A Raquel F Esteves; A Filipa Domingues; I Luísa Ferreira; Cristina Januário; Russell H Swerdlow; Catarina R Oliveira; Sandra M Cardoso
Journal:  Mitochondrion       Date:  2008-04-06       Impact factor: 4.160

8.  Parkinson's disease transgenic mitochondrial cybrids generate Lewy inclusion bodies.

Authors:  Patricia A Trimmer; M Kathleen Borland; Paula M Keeney; James P Bennett; W Davis Parker
Journal:  J Neurochem       Date:  2004-02       Impact factor: 5.372

Review 9.  Coupling the mitochondrial transcription machinery to human disease.

Authors:  Gerald S Shadel
Journal:  Trends Genet       Date:  2004-10       Impact factor: 11.639

Review 10.  Genetic findings in Parkinson's disease and translation into treatment: a leading role for mitochondria?

Authors:  V Bogaerts; J Theuns; C van Broeckhoven
Journal:  Genes Brain Behav       Date:  2007-08-03       Impact factor: 3.449

View more
  23 in total

Review 1.  Stem cell-based models and therapies for neurodegenerative diseases.

Authors:  Shilpa Iyer; Khaled Alsayegh; Sheena Abraham; Raj R Rao
Journal:  Crit Rev Biomed Eng       Date:  2009

2.  Reduced expression of peroxisome-proliferator activated receptor gamma coactivator-1alpha enhances alpha-synuclein oligomerization and down regulates AKT/GSK3beta signaling pathway in human neuronal cells that inducibly express alpha-synuclein.

Authors:  Abdul Shukkur Ebrahim; Li-Wen Ko; Shu-Hui Yen
Journal:  Neurosci Lett       Date:  2010-02-21       Impact factor: 3.046

Review 3.  The unresolved role of mitochondrial DNA in Parkinson's disease: An overview of published studies, their limitations, and future prospects.

Authors:  Amica C Müller-Nedebock; Rebecca R Brennan; Marianne Venter; Ilse S Pienaar; Francois H van der Westhuizen; Joanna L Elson; Owen A Ross; Soraya Bardien
Journal:  Neurochem Int       Date:  2019-06-21       Impact factor: 3.921

4.  Mitochondrial gene therapy augments mitochondrial physiology in a Parkinson's disease cell model.

Authors:  Paula M Keeney; Caitlin K Quigley; Lisa D Dunham; Christina M Papageorge; Shilpa Iyer; Ravindar R Thomas; Kathleen M Schwarz; Patricia A Trimmer; Shaharyar M Khan; Francisco R Portell; Kristen E Bergquist; James P Bennett
Journal:  Hum Gene Ther       Date:  2009-08       Impact factor: 5.695

5.  Therapeutic potential of melatonin and its analogs in Parkinson's disease: focus on sleep and neuroprotection.

Authors:  Venkatramanujam Srinivasan; Daniel P Cardinali; Uddanapalli S Srinivasan; Charanjit Kaur; Gregory M Brown; D Warren Spence; Rüdiger Hardeland; Seithikurippu R Pandi-Perumal
Journal:  Ther Adv Neurol Disord       Date:  2011-09       Impact factor: 6.570

6.  Low Levels of Prohibitin in Substantia Nigra Makes Dopaminergic Neurons Vulnerable in Parkinson's Disease.

Authors:  Debashis Dutta; Nilufar Ali; Emili Banerjee; Raghavendra Singh; Amit Naskar; Ramesh Kumar Paidi; Kochupurackal P Mohanakumar
Journal:  Mol Neurobiol       Date:  2017-01-06       Impact factor: 5.590

7.  Vulnerability of mesostriatal dopaminergic neurons in Parkinson's disease.

Authors:  Tomás González-Hernández; Ignacio Cruz-Muros; Domingo Afonso-Oramas; Josmar Salas-Hernandez; Javier Castro-Hernandez
Journal:  Front Neuroanat       Date:  2010-10-20       Impact factor: 3.856

8.  Glycolysis-respiration relationships in a neuroblastoma cell line.

Authors:  Russell H Swerdlow; Lezi E; Daniel Aires; Jianghua Lu
Journal:  Biochim Biophys Acta       Date:  2013-01-10

9.  Parkinson's disease brain mitochondria have impaired respirasome assembly, age-related increases in distribution of oxidative damage to mtDNA and no differences in heteroplasmic mtDNA mutation abundance.

Authors:  Charles R Arthur; Stephanie L Morton; Lisa D Dunham; Paula M Keeney; James P Bennett
Journal:  Mol Neurodegener       Date:  2009-09-23       Impact factor: 14.195

10.  Reduced axonal transport in Parkinson's disease cybrid neurites is restored by light therapy.

Authors:  Patricia A Trimmer; Kathleen M Schwartz; M Kathleen Borland; Luis De Taboada; Jackson Streeter; Uri Oron
Journal:  Mol Neurodegener       Date:  2009-06-17       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.